4//SEC Filing
Palmer Pamela P 4
Accession 0001209191-23-007816
CIK 0001427925other
Filed
Feb 7, 7:00 PM ET
Accepted
Feb 8, 4:46 PM ET
Size
5.4 KB
Accession
0001209191-23-007816
Insider Transaction Report
Form 4
Palmer Pamela P
DirectorChief Medical Officer
Transactions
- Tax Payment
Common Stock
2023-02-06$2.02/sh−681$1,376→ 38,777 total
Footnotes (4)
- [F1]Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs.
- [F2]Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.
- [F3]Balance includes non-reportable acquisition of 500 shares of Common Stock through the Company's Employee Stock Purchase Plan.
- [F4]Reflects a 1-20 reverse stock split which became effective on October 25, 2022.
Documents
Issuer
ACELRX PHARMACEUTICALS INC
CIK 0001427925
Entity typeother
Related Parties
1- filerCIK 0001511365
Filing Metadata
- Form type
- 4
- Filed
- Feb 7, 7:00 PM ET
- Accepted
- Feb 8, 4:46 PM ET
- Size
- 5.4 KB